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Quantification of creatinine kinetic parameters in patients with
acute renal failure.
Background. Urea kinetic modeling (UKM) and creatinine (Cr)
kinetic modeling (CKM) are used in the nutritional evaluation of
end-stage renal disease (ESRD) patients. Both the UKM-derived
normalized protein catabolic rate (nPCR) and the CKM-derived
estimate of lean body mass (LBM) may also provide important
information in critically ill acute renal failure (ARF) patients.
Estimation of LBM may be particularly useful as previous data
demonstrate that malnutrition adversely influences outcome in
ARF patients.
Methods. Eleven critically ill ARF patients (age 52 6 21 years;
mean 6 SD) treated with continuous venovenous hemofiltration
(CVVH) were the study group. They were analyzed at steady state
with a single-pool variable-volume model that determined the
creatinine generation rate (GCr) by a methodology that we have
previously described.
Results. The CVVH ultrafiltrate production rate was 913 6 49
ml/hr, yielding a blood Cr clearance of 15.2 6 0.9 ml/min and a
steady state serum Cr of 3.4 6 1.7 mg/dl. Daily creatinine
generation normalized to body wt (creatinine index: CI) was 6.3 6
0.8 and 10.6 6 3.0 mg/kg/day for females (N 5 4) and males (N 5
7), respectively (P , 0.05). Estimated mean LBM was 30.0 6 2.0
and 41.2 6 7.0 kg in females and males, respectively (P , 0.05),
while the same parameter normalized to body wt was 0.50 6 0.05
and 0.52 6 0.10, respectively. These values are substantially lower
than those previously reported for both normal and ESRD
patients. Regression analysis demonstrated both GCr (r
2 5 0.96;
P , 0.001) and LBM (r2 5 0.96; P , 0.001) were significantly
correlated with steady state serum Cr in a linear manner. How-
ever, no significant correlation (r2 5 0.06; P 5 0.24) between
nPCR and CI was observed.
Conclusions. These data suggest critically ill ARF patients have
severe somatic protein depletion. This malnourished state is likely
due to deficits established prior to the development of ARF, such
as those secondary to underlying chronic illnesses or prolonged
hospitalization, and deficits related to acute hypercatabolism.
Quantitative assessment of malnutrition in ARF patients with this
CKM-based methodology may permit a better understanding of
predisposing factors and, consequently, facilitate the development
of interventions designed to prevent malnutrition in these pa-
tients.
Recent studies demonstrate that mortality rates in criti-
cally ill, dialysis-dependent patients with acute renal failure
(ARF) remain high [1–5]. Numerous factors may contrib-
ute to these high mortality rates, which persist despite
significant recent improvements in dialysis equipment, an-
timicrobial agents, and critical care technology. One of
these factors is the present willingness of clinicians to
provide renal replacement therapy (RRT) to increasingly
sicker patients. By use of methods that estimate illness
severity quantitatively, recent analyses [5–8] have demon-
strated underlying co-morbidities of a chronic nature, such
as heart disease and renal insufficiency, and an acute
nature, such as sepsis and hepatic failure, influence ARF
outcome in the intensive care unit (ICU). However, a
clinical characteristic that has not been assessed adequately
as a factor potentially influencing ARF outcome is nutri-
tional status.
In stable end-stage renal disease (ESRD) patients, quan-
titative nutritional information can be obtained through
urea kinetic modeling (UKM) due to the rough equivalence
between normalized protein catabolic rate (nPCR) and
dietary protein intake [9]. (Although the more appropriate
term for nPCR is the “protein equivalent of the urea
nitrogen appearance rate” [10], nPCR is used subsequently
because it is the more widely used term among clinical
nephrologists.) Likewise, both Keshaviah et al [10] and
Canaud et al [11] have employed creatinine (Cr) kinetic
modeling (CKM) in the ESRD population to estimate
somatic protein stores or lean body mass (LBM), another
quantitative nutritional marker. Previous studies [12–14]
have suggested both nPCR and LBM are inversely related
to morbidity and mortality in ESRD patients.
Some groups, including our own, also have recently
begun to use UKM to quantify patient and treatment
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parameters in ARF [15–19]. However, the numerous clin-
ical differences between stable ESRD patients and critically
ill ARF patients suggest that the results derived from
quantification methods may have entirely different impli-
cations in the two patient populations. For example, rather
than being a surrogate for dietary protein intake, nPCR in
critically ill ARF patients may be more appropriately
viewed as a marker of illness acuity.
To our knowledge, no investigators have attempted to
adapt CKM methods for use in ARF. Because somatic
protein malnutrition adversely influences outcome in criti-
cally ill patients, including those with ARF, CKM may
provide useful information in the management of these
patients. Therefore, in the present investigation, we em-
ployed CKM in a series of critically ill, RRT-dependent
ARF patients to estimate LBM. Our results demonstrate
that the Cr generation rate and LBM are abnormally low in
ICU ARF patients, and suggest these abnormalities may
play a role in the high mortality rate of this patient group.
METHODS
Patient and treatment characteristics
Eleven critically ill, oligoanuric ARF patients who re-
ceived continuous venovenous hemofiltration (CVVH) at
Indiana University Hospital comprised the study group. In
a previous publication the clinical characteristics and re-
sults of steady state UKM analyses for this patient group
were reported [15]. All patients were in an intensive care
unit and received no nutrition by mouth during the study
period. The standard CVVH operating protocol was ob-
served for all patients [20]. The extracorporeal circuit
included an Amicon-20 polysulfone hemofilter (Amicon,
Danvers, MA, USA). Bicarbonate-based replacement flu-
ids were administered in a pre-filter mode. Blood flow was
generated by a roller pump (Renal Systems, Minneapolis,
MN, USA) and an infusion pump (Baxter Healthcare,
Deerfield, IL, USA), set at 1000 ml/hr, acted as an ultra-
filtrate governor. Pertinent biochemical data included
blood urea nitrogen concentration (BUN) and serum cre-
atinine (SCr) values, determined every 6 to 12 hours, and
pre-treatment serum albumin and cholesterol values. In
addition, 24-hour ultrafiltrate production rates were re-
corded daily. Finally, severity of illness was estimated by
determining the Acute Physiology and Chronic Health
Evaluation (APACHE) II score [21] on the day of CVVH
initiation.
Creatinine kinetic analyses
During each patient’s CVVH course, the steady state
period was defined as the first 24 hour period during which
both BUN and SCr varied by less than 5%. Blood Cr
clearance (KCr) was obtained from an expression for predi-
lutional hemofiltration derived by Ofsthun, Colton and
Lysaght [22], with an assumed sieving coefficient of 1.0. As
the vast majority of patients in the study were anuric,
endogenous creatinine clearance was not determined.
For each patient, the creatinine generation rate (GCr)
was determined from the steady state values of SCr and KCr
by use of a variable-volume, single-pool model that we have
previously described for urea [15]. In this previous investi-
gation [15], urea distribution volume was also determined
in each patient. As previous studies [11, 23] have demon-
strated creatinine distribution space approximates that of
urea (that is, total body water), creatinine volume of
distribution (Vcr) was estimated by the previously deter-
mined urea distribution volume in each patient.
As originally proposed by Forbes [24] and more recently
demonstrated by Johansson, Attman and Haraldsson [25],
the appropriate equation relating LBM to GCr is dependent
upon dietary factors. For patients provided a meat-free diet
(as in this study), LBM is related to GCr in the following
manner:
LBM ~kg! 5 20.7 1 0.0241 3 GCr (Eq. 1)
where GCr is expressed in mg/day for this expression.
Finally, Cr production rates predicted by the Cockcroft-
Gault equations [26] were compared to those determined
by CKM:
Production ~mg/day! in males 5 28.0 2 0.2
3 age ~years! (Eq. 2a)
Production ~mg/day! in females 5 23.8 2 0.17
3 age ~years! (Eq. 2b)
RESULTS
Patient and treatment data
Seven males and four females comprised the study
group, only one of whom survived to hospital discharge
(91% in-hospital mortality). The demographic characteris-
tics of the group at baseline appear in Table 1. The mean
baseline APACHE II score, measured on the day of CVVH
initiation, was 29.9 6 6.1 (mean 6 SD), confirming a high
acuity of illness. Although the etiologies of both the
baseline hypocholesterolemia (mean serum cholesterol,
104 6 27 mg/dl) and hypoalbuminemia (mean serum
albumin, 3.0 6 0.8 g/dl) were probably multifactorial,
malnutrition may have contributed to both of these bio-
chemical abnormalities.
Nine of the 11 patients had at least one of the following
Table 1. Characteristics of CVVH patients
Age years 52 6 21
Male/female 7/4
Serum creatinine mg/dl 5.6 6 2.6
Serum albumin g/dl 3.0 6 0.8
Serum cholesterol mg/dl 104 6 27
APACHE II score 29.9 6 6.1
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underlying chronic illnesses: congestive heart disease, hy-
pertension, coronary artery disease, chronic obstructive
pulmonary disease, Hodgkin’s disease, chronic myeloge-
nous leukemia, and hepatitis C. Of these nine patients, five
had recently undergone organ transplantation. One of the
two patients free of underlying chronic diseases developed
ARF toward the end of a subacute course of Wegener’s
granulomatosis. Therefore, of the 11 patients, only one,
whose ARF was related to acute pancreatitis and sepsis,
was totally free of underlying medical problems prior to the
development of ARF.
The CVVH therapy characteristics are shown in Table 2.
The CVVH ultrafiltrate production rate was 913 6 49
ml/hr, resulting in a blood-side filter KCr of 15.2 6 0.9
ml/min. This level of delivered therapy resulted in a fall in
the SCr from 5.6 6 2.6 mg/dl pre-CVVH to 3.4 6 1.7 mg/dl
at steady state (P , 0.05). The BUN at steady state was
78 6 18 mg/dl, resulting in a mean steady state BUN/SCr
ratio of 28.0 6 14.2.
Creatinine kinetic analyses
Results of the CKM analyses appear in Table 3. The
kinetically-derived GCr (mg/day) was used to determine the
measured creatinine index (CI: mg/kg/day), while the pre-
dicted CI was estimated from the Cockcroft-Gault equa-
tion. As expected, GCr and measured CI were both signif-
icantly higher in males than females. However, in both
males and females, mean measured CI values were signif-
icantly less than measured values reported by Canaud et al
[11] for stable chronic HD patients. In addition, measured
CI values in this ARF population were significantly less
than those predicted by the Cockcroft-Gault equation. On
the other hand, these data from critically ill ARF patients
are similar to creatinine excretion data previously reported
by Pesola, Akhavan and Carlon for a similar group of ICU
patients [27].
The suggestion of an overall marked depletion of muscle
mass in this patient group was further evaluated by deter-
mination of LBM (Table 4). As all patients were adminis-
tered either intravenous alimentation or gastric feedings,
an equation specifically developed by Forbes [24] for
patients receiving a meat-free diet was used to determine
LBM. Although LBM (in kg) was significantly higher in
males than females (41.2 6 7.0 and 30.0 6 2.0, respectively;
P , 0.05), there was no difference between the two groups
Fig. 1. Creatinine generation rate (A) and lean body mass (B) as a
function of serum creatinine concentration at steady state. A significant
linear relationship is observed in both A (r2 5 0.96; P , 0.001) and B
(r2 5 0.96; P , 0.001).
Table 2. CVVH therapy characteristics
Ultrafiltration rate ml/hr 913 6 49
Creatinine clearance ml/min 15.2 6 0.9
Steady state SCr mg/dl 3.4 6 1.7
Steady state BUN mg/dl 78 6 18
Steady state BUN/SCr 28.0 6 14.2
Table 3. Measured vs. predicted creatinine index (CI)
Females Males Group
Steady state SCr
a mg/dl 2.0 6 0.5 4.2 6 1.7 3.4 6 1.7
Generationa mg/day 387 6 82 850 6 290 681 6 327
Measured CIa mg/kg/day 6.3 6 0.8 10.6 6 3.0 9.0 6 3.2
Predicted CI mg/kg/day 14.0 6 3.6 18.3 6 4.4 16.7 6 4.5
a P , 0.05, female vs. male
Table 4. Lean body mass (LBM) estimations
Females Males Group
LBM kga 30.0 6 2.0 41.2 6 7.0 37.1 6 7.9
Normalized LBM kg/kg 0.50 6 0.05 0.52 6 0.10 0.51 6 0.09
a P , 0.05, female v. male
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when LBM was normalized to the steady state body wt.
Based on normalized LBM (kg/kg) values of 0.60 and 0.70
for females and males, respectively, being indicative of
“extremely low” LBM [10], every ARF patient in the
present study fell in this category. Due to the expected
significant difference between mean normalized LBM val-
ues in males and females, the relative extent of LBM loss
appeared to be greater in the former group.
Regression analyses
The relationship between CKM-derived parameters and
steady state SCr is shown in Figure 1. In Figure 1A, the
significant linear correlation between GCr and SCr at steady
state is demonstrated. Based on the equation from which
LBM was derived (Equation 1), the similar significant
relationship between LBM and SCr at steady state was
expected (Fig. 1B). These data indicate the steady state
value at which the SCr plateaus, in conjunction with the
delivered Cr clearance, may be useful as a rough approxi-
mation of somatic protein stores in critically ill patients
treated with continuous RRT (CRRT). In addition, as
suggested by Lowrie and Lew [28] for ESRD patients, these
data suggest the steady state SCr in ARF patients is more
appropriately regarded as a nutritional parameter than as a
treatment adequacy parameter.
The mean nPCR at steady state was 1.69 6 0.73 g/kg/day,
consistent with previously reported values for patients in
this clinical situation [17, 29–31]. When nPCR was re-
gressed with normalized creatinine generation (CI), no
significant relationship between these two parameters was
observed (Fig. 2). These results conflict with data from the
ESRD population [10, 11] describing a significant linear
relationship between nPCR and CI or LBM.
DISCUSSION
Several groups have employed CKM as a method by
which somatic protein stores can be estimated in ESRD
patients [10, 11, 25, 32–34]. In a study reported by Canaud
et al, the creatinine index was found to be directly related
to survival in a group of 90 ESRD patients studied over a
six to 36 month period [11]. In addition, these investigators
observed a significant linear relationship between nPCR, a
marker of dietary protein intake, and creatinine index, a
marker of muscle mass. A similar linear relationship be-
tween nPCR and creatinine production rate has also been
reported by Keshaviah et al in ESRD patients [10]. In this
latter study, LBM normalized to body wt was below the
lower limit of normal established for males and females
(0.70 and 0.60, respectively) in 66% of chronic peritoneal
dialysis patients.
In the present study, CKM methods were adapted to
estimate somatic protein stores in a group of critically ill
ARF patients. Based on comparisons both to values pre-
dicted for normal individuals and values measured in
ESRD patients, our CKM analyses suggest that the extent
of somatic protein depletion was substantial in this ARF
population. Based on the Cockcroft-Gault equation, the
mean predicted CI for the entire patient group in the
present study was approximately 17 mg/kg/day (Table 4), a
value significantly greater than the mean actual (measured)
CI for this ARF group (9.0 mg/kg/day). In addition, the
mean measured CI in the present study was substantially
less than the corresponding value (21 mg/kg/day) deter-
mined in the Canaud study involving chronic HD patients,
in whom the mean age (55 years) was quite similar to that
in the present study (52 years). The LBM determinations in
the present study confirmed the severity of the somatic
protein malnutrition. For all patients in the study, the
normalized LBM was less than previously established cri-
teria below which severe somatic protein depletion is felt to
be present. This marked degree of depletion may have been
one factor mediating the high overall mortality (91%) of
these specific patients.
Previous investigations suggest that malnutrition influ-
ences outcome in ICU ARF patients [35–38]. However,
these studies have primarily focused on the effect of
nutritional support on outcome. As Ikizler and Himmelfarb
have correctly noted in a recent review, these studies have
failed to establish malnutrition per se as an independent
risk factor for death in ARF patients and leave open the
possibility that malnutrition is simply a byproduct of con-
comitant critical illness [39]. The exception to this general
deficiency of previous studies is an investigation recently
published in preliminary form by Fiaccadori et al [40]. In
this study, the presence or absence of malnutrition was
established with the subjective global assessment [41]. In
addition, nutritional status was assessed by a variety of
other techniques, including arm muscle area (AMA) and
Fig. 2. Normalized protein catabolic rate as a function of creatinine
index. The relationship between the two parameters is not significant (r2 5
0.06; P 5 0.23).
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SCr measurements. In malnourished patients, AMA and
SCr, both of which are reflective of somatic protein stores,
were significantly lower than the same parameters in pa-
tients considered to have normal nutritional status. In turn,
malnutrition was found to be a significant independent
predictor of death by logistic regression analysis. Of note,
Paganini et al have also recently reported that a relatively
low rate of increase in serum creatinine is independently
associated with poor clinical outcome in ICU ARF patients
[19]. These recent data demonstrate the adverse impact of
somatic protein depletion on outcome in ARF patients and
attest to the importance of evaluating somatic protein
status in this group.
In addition to having evidence of severe somatic protein
depletion, the patients in the present study had other
characteristics possibly consistent with malnutrition. One of
these characteristics was severe hypocholesterolemia, for
which one etiology could have been malnutrition. The
depressed baseline serum albumin values (mean, 3.0 6 0.8
g/dl) also could have been due to malnutrition-related
visceral protein depletion. However, the validity of serum
albumin’s role as a sensitive marker of nutritional status has
been challenged [42], and the hypoalbuminemia in these
patients has at least two other potential explanations. One
is volume overload with resultant hemodilution (vide infra).
The other potential explanation is albumin’s role as a
negative acute-phase reactive protein whose synthesis is
impaired by inflammatory processes. In chronic hemodial-
ysis patients, recent data indicate serum albumin is signif-
icantly and negatively correlated with two strong acute-
phase proteins: C-reactive protein (CRP) and serum
amyloid A (SAA) [43, 44]. Because many of the patients in
the present study had sepsis, their hypoalbuminemia may
have been more strongly related to a generalized inflam-
matory state rather than malnutrition per se.
For ESRD patients in whom neither net catabolism or
anabolism is present, the nPCR is considered an appropri-
ate surrogate for dietary protein intake [9]. Previous studies
in this population [10, 11] have demonstrated a significant
linear relationship between nPCR and markers of somatic
protein status, LBM and CI, suggesting that higher protein
intake leads to greater muscle mass. Therefore, as recently
discussed by Canaud et al, UKM and CKM provide com-
plementary nutritional information in stable ESRD pa-
tients [11]. In the present study, we also assessed the
relationship between nPCR and CKM-derived nutritional
parameters. As opposed to the above ESRD studies, no
significant relationship between nPCR and either CI or
LBM was observed for the ARF patient population as-
sessed in the present study. The disparate implications of
nPCR in stable ESRD patients and unstable ARF patients
accounts for this uncoupling of UKM and CKM parameters
in ARF. Because a characteristic feature of hypercatabolic
ARF is net negative nitrogen balance [30, 39, 45], nPCR in
this setting is not a surrogate for dietary protein adminis-
tration. Instead, nPCR in ARF is more appropriately
regarded as a marker of acute illness severity and hyperca-
tabolism-induced turnover of protein. As such, it is not
necessarily expected to be correlated with somatic protein
stores. In addition, acute illness may influence creatinine
generation and excretion (vide infra).
Our data demonstrating an abnormally low rate of
creatinine generation in critically ill ARF patients are
similar to those reported by Pesola, Akhavan and Carlon
[27]. These investigators measured urinary creatinine ex-
cretion rate (normalized to body wt) in 209 ICU patients
with acute organ dysfunction. Using both actual and lean
body wt for calculation purposes, they found 37% and 30%
of patients, respectively, to have creatinine excretion rates
less than 10 mg/kg/day. Patients with creatinine excretion
rates in this low range were significantly more likely to be
female and elderly (age . 60 years). Creatinine excretion
rate has also been found to be a predictor of outcome in
acutely ill patients [46]. In a study involving 282 hospital-
ized patients, Harvey et al showed a low creatinine-height
index was significantly associated with sepsis and this index
was significantly lower in dying versus surviving patients
[46].
The effect of acute illness or a catabolic insult on urinary
creatinine excretion has been assessed in previous studies.
In the immediate period following serious traumatic injury,
Schiller, Long and Blakemore [47] found the mean urinary
creatinine excretion rate to be substantially higher than the
mean predicted value based on gender and height. How-
ever, creatinine excretion frequently fell to abnormally low
levels in patients hospitalized for prolonged periods. This
decrease in creatinine excretion frequently was accompa-
nied by substantial weight loss, which the authors attributed
to loss of lean body mass. Of note, these phenomena of
increased creatinine excretion in response to a catabolic
event [48] and decreasing creatinine excretion during pro-
longed hospitalization [49] have been observed by other
investigators. Schiller et al also assessed the effect of
serious non-traumatic illness on creatinine excretion in
patients with antecedent malnutrition [47]. In these pa-
tients, creatinine excretion was initially depressed markedly
and only spuriously “normalized” after an acute insult
(such as surgery and infection) occurred.
For several reasons, the above findings by other investi-
gators are applicable to the patients comprising the present
study with respect to the possible development of somatic
protein malnutrition. First, many patients in the present
study had been hospitalized for significant periods of time
prior to the development of ARF. This was particularly
applicable to patients transferred to our tertiary care
referral center from outlying institutions. However, be-
cause records from these outside hospitals were frequently
incomplete, it was impossible to determine the extent of
any possible weight loss that may have occurred prior to the
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development of ARF in the majority of patients. In addi-
tion, the presence of underlying chronic illnesses predis-
posing these patients to malnutrition may have been con-
tributory. Second, although the mean nPCR was markedly
elevated in these patients, this marked hypercatabolism was
not sufficient to result in an increase in the rate of
creatinine generation. Based on the results of the Schiller
et al study [47], this suggests the present group of patients
had marked depletion of lean body mass even prior to the
development of ARF. This advanced malnutrition may have
contributed to the high in-hospital mortality of this group, as
has been suggested by our group [50] and others [51, 52].
In the CKM methodology that we employed, some
potential weaknesses require additional discussion. First,
the assumed hemofilter sieving coefficient of 1.0 for creat-
inine may have not been strictly applicable in all patients at
steady state. However, previous reports suggest that hemo-
filters with preserved ultrafiltration, which was a prerequi-
site in the present study, maintain small solute sieving
coefficients very close to unity [53, 54]. Second, in deter-
mining CI and normalized LBM, we used actual body wt at
steady state rather than ideal body wt. The possible pres-
ence of significant volume overload at steady state could
have resulted in spuriously decreased values of these CKM
parameters. However, the mean duration of CVVH was
nearly one week (6.7 days) prior to the steady state analysis
period. Because correction of volume overload occurred
during this period, the attainment of euvolemia or near-
euvolemia probably had occurred by the time the analyses
were performed. In addition, the estimate of total body
water (mean, 0.57 liter/kg) obtained in our previous UKM
studies of this same group [15] suggests attainment of
euvolemia occurred in most patients. Although the pres-
ence of a small degree of volume overload at steady state
may have modestly influenced the absolute values for mean
LBM and CI, the overall trends would not have been
affected substantively. The third potential weakness in our
CKM analyses relates to the equation used for LBM
determinations. We employed an equation that did not
account for metabolic clearance because this adaptive
mechanism has been documented only in chronic renal
failure [55]. In addition, although recent CKM analyses in
ESRD patients have accounted for metabolic clearance [10,
11], the validity of doing so has recently been questioned
[25]. The assumption of single-pool kinetics for both urea
and creatinine is also a potential shortcoming. However,
due to the low rate of extracorporeal removal of these
solutes during CVVH, particularly in relation to their
relatively high intercompartmental mass transfer rates, a
significant disequilibrium is highly unlikely. Nevertheless,
future ARF studies should address this issue and our
assumption of the equivalence of the distribution volumes
for urea and creatinine, the latter of which has been
documented in ESRD patients [11, 23]. Finally, use of a
second technique (such as, bioimpedance) designed to
provide corroborative somatic protein data may have
strengthened the present study.
In summary, this study demonstrates CKM is a useful
tool in the assessment of somatic protein stores in critically
ill ARF patients. Our data suggest these patients have
marked depletion of somatic protein stores, a factor that
may contribute to the high mortality rates in this patient
population. The etiology of this malnourished state is
probably multifactorial, including underlying chronic ill-
nesses, prolonged hospitalization, and ongoing hyperca-
tabolism. Quantitative assessment of malnutrition in ARF
patients may permit a better understanding of predisposing
factors, and consequently facilitate the development of inter-
ventions designed to prevent malnutrition in these patients.
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APPENDIX
Abbreviations used in this article are: AMA, arm muscle area;
APACHE, Acute Physiology and Chronic Health Evaluation; ARF, acute
renal failure; BUN, blood urea nitrogen; Cr, creatinine; CI, creatinine
index; CKM, creatinine kinetic modeling; CRP, C-reactive protein;
CRRT, continuous renal replacement therapy; CVVH, continuous veno-
venous hemofiltration; ESRD, end-stage renal disease; GCr, creatinine
generation rate; ICU, intensive care unit; KCr, blood creatinine clearance;
LBM, lean body mass; nPCR, normalized protein catabolic rate; RRT,
renal replacement therapy; SAA, serum amyloid A; SCr, serum creatinine;
UKM, urea kinetic modeling; VCr, creatinine volume of distribution.
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